Your Stress Response Is Stuck. Your Genes May Be Why.

FKBP5 encodes a protein that sits on your cortisol receptors and helps them work properly. When cortisol binds to its receptor, FKBP5 assists the receptor in delivering the signal to turn off further cortisol production. It’s a feedback mechanism, a biological brake pedal.

The rs1360780 variant in FKBP5, carried by approximately 30% of the population, impairs this feedback mechanism. Your cortisol receptors become less responsive to cortisol’s shutdown signal. The result is a prolonged cortisol elevation after stress, as if your biological brake pedal is stuck partially depressed.

You experience this as an inability to recover. A stressful meeting at work leaves you wired for hours. A conflict with a partner keeps your nervous system activated long after the conversation ends. You startle easily. Your baseline anxiety is higher. You may feel like you’re always running on fumes, even after a full night of sleep.

COMT encodes the enzyme catechol-O-methyltransferase, which breaks down dopamine, epinephrine, and norepinephrine. These are your rapid-response stress hormones, released within seconds of a perceived threat. COMT is the cleanup crew.

The Val158Met variant, present in approximately 25% of the population as a homozygous slow variant, reduces COMT’s activity by 30-40%. Your body clears stress hormones more slowly. Adrenaline and norepinephrine linger in your bloodstream longer, keeping your nervous system in a heightened state even after the stressor has passed.

You feel this as chronic low-level anxiety, hypervigilance, and difficulty shifting your attention. You’re sensitive to caffeine and stimulants, which push even more adrenaline into a system already struggling to clear it. You may grind your teeth, have tension headaches, or notice your heart rate stays elevated longer than it should after exertion or stress.

NR3C1 encodes the glucocorticoid receptor, the protein that sits on the surface of cells and receives cortisol’s signal. When cortisol docks onto this receptor, it tells the cell how to respond: increase energy production, dampen inflammation, suppress immune activity. NR3C1 is the cortisol receptor itself.

Variants like BclI and N363S, present in approximately 20-30% of the population, alter how efficiently the glucocorticoid receptor works. The N363S variant, in particular, increases cortisol receptor sensitivity, which sounds beneficial but often isn’t. Your cells over-respond to cortisol, amplifying suppression of immune function and increasing vulnerability to infection and autoimmune flares.

You may notice that stress triggers or worsens autoimmune symptoms. You catch every cold that circulates. Your immune system feels dysregulated. Alternatively, other NR3C1 variants reduce receptor sensitivity, meaning your cells don’t respond adequately to cortisol’s signal, leaving you stuck in an inflamed state even as cortisol rises.

CYP21A2 encodes 21-hydroxylase, an enzyme critical to the first committed step in cortisol synthesis in your adrenal glands. It sits in the steroidogenesis pathway, converting pregnenolone into the substrates your body uses to make cortisol, DHEA, and androgens. When this enzyme works well, your adrenal glands produce cortisol appropriately.

Variants in CYP21A2 are uncommon in their severe form (congenital adrenal hyperplasia affects about 1 in 15,000), but milder variants affect approximately 1 in 60 people as carriers. Even partial variants can shift your cortisol and androgen balance, causing either insufficient cortisol production or excessive androgen production, depending on which part of the pathway is affected.

You may experience low cortisol symptoms: extreme fatigue, salt cravings, difficulty handling stress, low blood pressure. Or you may experience high androgen symptoms: unwanted facial hair, irregular periods, acne, or elevated testosterone. Your adrenal glands simply can’t produce the right ratios of hormones your body needs.

MAOA encodes monoamine oxidase A, the enzyme that degrades dopamine, serotonin, norepinephrine, and epinephrine in your brain. It’s a critical cleanup enzyme in your prefrontal cortex and amygdala, the regions that regulate stress perception and emotional control.

The MAOA-L (low-activity) variant, present in approximately 30-40% of males, reduces this enzyme’s activity by 40% or more. Neurotransmitters accumulate in your brain, amplifying stress sensitivity, emotional reactivity, and amygdala activation in response to perceived threats. You become more likely to perceive situations as threatening and to react with heightened emotional intensity.

You experience this as irritability, a short fuse, difficulty managing anger, and heightened emotional reactivity to minor stressors. You may feel like your emotions are overwhelming or that you overreact in situations others seem to handle calmly. Over time, this pattern of high reactivity keeps your HPA axis chronically activated.

SLC6A4 encodes the serotonin transporter, the protein responsible for recycling serotonin back into neurons after it’s been released into the synapse. More serotonin recycling means less serotonin available to buffer stress and regulate mood.

The 5-HTTLPR short allele, carried by approximately 40% of the population, reduces SLC6A4 expression by 20-40%. Your neurons recycle serotonin more aggressively, leaving less of it in the space between cells to buffer stress. Under chronic stress, serotonin becomes rapidly depleted, and your mood and stress resilience collapse more quickly than in people with the long allele.

You may experience rapid mood deterioration under workload stress, anxiety that develops suddenly without obvious trigger, and difficulty bouncing back emotionally from setbacks. You’re more vulnerable to burnout because your brain’s serotonin reserve depletes faster. Under sustained stress, depression or anxiety may emerge even if you’ve never experienced it before.